Breast cancer risk estimation in families with history of breast cancer. by Muhonen, T. et al.
British Joumal ofCancer(1997) 76(9), 1228-1231
© 1997 Cancer Research Campaign
Breast cancer risk estimation in families with history of
breast cancer
T Muhonen', H Eerola12, P Vehmanen2, H Nevanlinna2, K Aktan', C Blomqvist', H Kaariainen3 and S Pyrhonenc
'Department of Oncology, Helsinki University Central Hospital, Finland; 2Department of Obstetrcs and Gynecology, Helsinki University Central Hospital, Finland;
3Family Federation of Finland
Summary Among 288 breast cancer patients (118 with bilateral disease and 165 with diagnosis before 40 years of age), we identified 26
families with a history of breast cancer, including a minimum of three first- or second-degree relatives. Complete pedigrees with verified
malignancy data from the Finnish cancer registry were constructed for 22 families. The median age at breast cancer diagnosis of the young
probands (< 40 years of age) was 35 years and of bilateral probands was 54 years. The relatives of the young probands were diagnosed with
breast cancer at a younger age (median age 54 years) than the relatives of the older (bilateral) probands (median age 60 years). Standard
life-table methods were used to compare the risk of breast cancer in the family members with that of the general population. Among the
relatives of the young probands, the increased breast cancer risk occurred in the early post-menopausal period, whereas the risk estimate for
the relatives of the bilateral probands closely followed that of the general population. In both groups, however, thosefamily members reaching
the age of 80 years had a cumulative probability of over 50% of developing breast cancer. The standard life-table method proved useful when
assessing the age-specific riskforfamilial breast cancer, taking into account numerous family members as well as their age at disease onset.
This kind of analysis can be performed in populations forwhich reliable cancer registry data are available. It provides a useful tool forselecting
individuals for imaging and mutation screening, counselling and experimental chemoprevention programmes.
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In epidemiological studies, an elevated risk for breast cancer has
been shown for relatives of breast cancer patients. The risk for
first-degree relatives is high if the breast cancer has been diag-
nosed at an early age; it is even higher if the patient has bilateral
breast cancer and is highest when the patient has bilateral breast
cancer diagnosed at an early age (Houlston et al, 1992a; Tulinius
et al, 1992). The reason may be the high probability ofhereditary
breast cancer cases among such patients as, for this group, breast
cancer family history is the single most prominent risk factor. A
family history of 3 or 4 cases of breast cancer in close relatives
may be indicative of such hereditary disease. However, as breast
cancer is a common disease oflate onset and often sporadic occur-
rence, family history alone may be insufficient for identifying
families with increased risk and with possible hereditary breast
cancer (Anderson, 1992). Instead, the cancercases may have accu-
mulated by chance, particularly if the family is very large and the
cancer cases have been diagnosed at older ages. There is an urgent
need for more accurate risk estimation methods to facilitate orga-
nization of focused breast cancer screening, counselling and
chemoprevention programmes (American Society of Human
Genetics, 1994). Here, we have used life tables to estimate risk for
breast cancer in 22 breast cancer families in comparison with risk
in the general population.
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MATERIALS AND METHODS
All breast cancerpatients diagnosed before 40 years of age or with
bilateral breast cancer at the Department of Oncology of Helsinki
University Central Hospital, 1987-1993, were identified (541
cases), and the surviving patients (348) were sent a family history
questionnaire. Questionnaires were retumed by 288 patients
(83%), 118 of whom had bilateral breast cancer and 165 of whom
were diagnosed before the age of 40 years. Five patients fulfilled
both criteria; 26 patients (16 patients in the young age group and
ten patients with bilateral disease) reported a family history
fulfilling our criteria for inclusion in the study, i.e. a minimum of
three breast or ovarian cancer patients who were first- or second-
degree relatives of each other. Two families had only two breast
cancer cases and an additional ovarian cancer case, thus fulfilling
the criteria.
The probands of these families were further interviewed by
researchers, and pedigrees were constructed accordingly. All
family data were verified in the Finnish population registry or in
local church archives, including data on the age of all family
members. The cancer diagnoses were verified through the Finnish
Cancer Registry, including the histories of relatives for whom no
diagnosis of cancer had been reported, and the age of each family
member at breast cancer onset was recorded. For 22 of the 26
families fulfilling our criteria, we were able to draw a pedigree
with reliable data on chronological age and age at breast cancer
onset for all female relatives. For the remaining four families, we
could not obtain sufficient information to reliably identify all the
relatives. In the 22 families, a total of77 women had breast cancer.
All the breast cancers diagnosed after the establishment of the
Finnish Cancer Registry in 1953 were verified by the Registry.
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Selection of individuals
All first-degree female relatives ofbreast cancer patients in the 22
pedigrees were selected for the life-table analysis for comparison
oftheir breast cancerrisk as a function ofage at onset to that ofthe
general population. This gave 211 individuals ranging in age from
0.1 to 92 years.
Risk of breast cancer in the population
The age-specific incidence rates of breast cancer came from the
Finnish Cancer Registry (Cancer Society of Finland, 1993). The
population incidence data were input into a BMDP statistical
program (Dixon, 1988). Forpractical reasons, these incidence data
were compressed into a sample of 1000 cases consisting of 892
women not developing breast cancer by the age of 85 years and
108 women developing breast cancer at different ages. For each 5-
or 10-year cohort, we coded the same percentage of women as
cases as there were in the whole population. The mean age ofeach
cohort was recorded as age ofonset for all cases in each cohort.
Statistical methods
The data were analysed with the BMDP Statistical Software
Package version 1993 running in a VAX/VMS system. The age of
breast cancer onset was calculated using the Kaplan-Meier
product limit estimate. The life-table method was used to estimate
the breast cancer hazard function. The age of onset of breast
cancer in the families was compared with that of general popula-
tion with the log rank (or Mantel-Cox) test, which gives equal
weight to all observations (Mantel, 1966). In order to minimize the
evident selection bias when comparing the families to general
population, the calculations were performed in four different
ways: those persons not having breast cancer were either included
in or excluded from the analysis or the calculations were only
based on individuals who eventually developed breast cancer. The
fourth and most conservative approach was to exclude all the
individuals who had identified the cancer families. After this
exclusion, there were only 14 breast cancer cases left for analysis.
RESULTS
Age at breast cancer diagnosis
The median age of breast cancer diagnosis of the probands of the
22 families was 38 years (range 26-75 years) compared with 58
years (range 32-89 years) for the relatives. For the young patients
(13 cases), the figures were 35 years (range 26-39 years) for
probands and 54 years (range 33-86 years) for relatives and, for
the bilateral cases (nines cases), 54 years (range 41-75 years) for
probands and 60 years (range 30-89 years) for relatives. The
Kaplan-Meier curves for breast cancer-free survival of all female
relatives of the probands are shown in Figure 1A, whereas Figure
lB gives the breast cancer-free survival for family members after
exclusion ofthose cases who had identified the cancer families.
The cumulative probability of living without breast cancer is
dramatically smaller in the cohorts of the relatives of the breast
cancer probands than in the general population (Table 1). The age
of 25% actuarial probability of breast cancer is 60 years for the
relatives of young probands and 62 years for the relatives of
bilateral probands. For the general population, 25% actuarial prob-
ability of breast cancer is not reached at all. The family members
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Figure 1 (A) Cumulative probability of avoiding breast cancer among all
first-degree female relatives of breast cancer patients. (B) Cumulative
probability of avoiding breast cancer among first-degree female relatives of
breast cancer patients when the two patients who identified the cancer
families are excluded. -, relatives of young (< 40 years) probands; - - -,
relatives of probands with bilateral disease; -, breast cancer patients of the
general population
have over 50% cumulative probability ofcontracting breast cancer
before reaching the age of80 years (Figure 1).
When only those individuals in the families who exhibit breast
cancer are compared with breast cancer patients in the general
population as a function of age at onset, only the relatives of the
young probands show a significantly lower age of onset than the
population (median 51 vs 63 years, P = 0.0002, log rank). The
relatives ofthe older (bilateral) probands have essentially the same
age distribution ofbreast cancer development as the general popu-
lation (median 60 vs 63 years, P = 0.2, log rank). There is a trend
to later onset ofbreast cancer among relatives as the age of onset
for the proband becomes higher, but the difference is not, however,
as large as the difference in the ages ofthe probands.
Breast cancer hazard function
The breast cancer hazard function curves are illustrated in Figure
2. When the hazard for all first-degree female relatives is
compared with that of the general population, the difference is
significant for relatives both ofyoung and ofbilateral probands, as
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Table 1 Number of breast cancer cases and the cumulative probability of avoiding breast cancer by age in families of young probands, bilateral probands and
population. Probands are excluded
Age range Families of young probands Families of bilateral probands Population/1000
(years) (n= 13) (n= 9)
No. of breast Cumulative risk No. of breast Cumulative risk No. of breast Cumulative risk
cancer cases cancer cases cancer cases
30-39 3 0.97 2 0.97 3 1.0
40-49 6 0.90 4 0.89 15 0.98
50-59 10 0.74 5 0.78 24 0.96
60-69 9 0.54 4 0.68 21 0.94
70-79 4 0.39 3 0.57 21 0.92
80-89 1 0.28 4 0.27 24 0.87
Total 33 22 108
0.2
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Figure 2 Annual breast cancer hazard among female first-degree relatives
of breast cancer patients who develop breast cancer. The hazard is
summarized for each 10-year period. Relatives of young (< 40 years)
probands; - - -, relatives of probands with bilateral disease; -, breast cancer
patients of the general population. The annual hazard of 0.2 reached by all
three groups means that all the patients developed breast cancer before the
end of the follow-up period
illustrated in Figure 2. To avoid selection bias, only those relatives
who developed breast cancer were included in the analysis. The
annual hazard for breast cancer among the relatives with breast
cancer ofthe bilateral (> 40 years) probands is identical to that for
the general population. In contrast, for the relatives of the young
probands, the hazard is greater. This difference is most marked in
the early post-menopausal period (Figure 2).
Breast cancer risk ratios
Based on the observed-expected ratio, the overall risk for breast
cancer development in all the first-degree relatives ofbreast cancer
patients is 7.6-fold (P < 0.0001, log rank) higher than in the
general population. When the breast cancer cases who identified
cancer families were removed from the analysis, the overall risk
was only 2.8-fold (P = 0.0002) higher. The risk for the remaining
relatives of young probands is 3.5 (P < 0.0001); for relatives of
bilateral probands, the value is 1.8 (P = 0.2). In order to avoid
selection bias, we also calculated the risk for breast cancer as a
function of age at onset in only those relatives who actually
develop breast cancer and compared it with that of the breast
cancer patients in the general population. The risk was 1.7-fold
(P = 0.0005) higher in all families pooled; in the families of the
young probands, RR = 2.0 (P < 0.0001) and, in families of the
bilateral (and older) probands, RR = 1.3 (P = 0.1).
DISCUSSION
We used standard life-table methods to characterize the risk of
breast cancer in families with a history of breast cancer and thus
possible hereditary breast cancer, and we compared the pattern of
breast cancer risk and disease onset in these families with a model
derived from the population-based cancer registry data. For inclu-
sion of the families, we have used the criteria of a minimum of
three affected members with breast or ovarian cancer who were
first- or second-degree relatives of each other - a simple and
straightforward approach. However, several breast cancer cases
may accumulate in a large family merely by chance, and further
problems arise from the fact that the disease is very common and
appears usually at a late age. Moreover, the well-known risk
factors are likely to coexist in siblings, confounding the interpreta-
tion ofgenetic origin (Chen et al, 1994).
Using the standard life-table method, we could demonstrate that
the first-degree family members of breast cancer patients had, on
average, a risk for breast cancer 2.8-fold that for women in the
general population (when the cases that identified a cancer family
were excluded from the analysis). This risk is identical to that
reported for first-degree relatives of unselected breast cancer
patients (Tulinius et al, 1992; Colditz et al, 1993). In contrast,
studies on first-degree relatives of patients with bilateral disease
(Houlston et al, 1992b) and on relatives less than 50 years ofage of
probands less than 40 years ofage (Houlston et al, 1992b) showed
much higherrisks, similarto thatobserved in our study when those
individuals necessary for selection of a family were also included
in the analysis. Similar risks have also been reported by Claus and
co-workers (Claus et al, 1990).
This increased risk for breast cancer is not solely attributable to
the higher frequency of breast cancers in the family members but
is also because ofthe fact that the breast cancers developed earlier
in these family members. The life-table method can also take into
account this factor in risk estimation. The relative risk of 1.7
reflects without bias the earlier onset of breast cancer in the rela-
tives developing breast cancer. Furthermore, the increased risk was
even more prominent in the families of the young probands
(RR = 2.0) than in the families ofthe bilateral (andolder)probands
(RR = 1.3). This observation is in agreement with earlier findings
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(Claus et al, 1990, 1993; Claus 1994; Houlston et al, 1992a).
Between 30 and 40 years ofage, the annual hazard ofthe relatives
of the young patients was already higher than for any age group
of the general population. Therefore these could form a suitable
target group for screening mammography even before the recom-
mended age of50 years. Analysis ofthe SwedishTwo-County trial
has shown that, for unselected women at 40-49 years of age,
screening mammography can reduce mortality by 19% if
performed annually (Tabar et al, 1995), and high rates of compli-
ance have been achieved when screening women under the age of
50 years at some family cancer clinics (Houlston et al, 1992b).
As the inclusion criteria for this and for some of the previous
analyses was the occurrence of a certain number of affected
members in a family, there is inevitably a selection bias. We have
reduced this by excluding the proband as well as two affected first-
degree family members. Another way to avoid this bias is by
comparing the age at breast cancer onset ofonly those individuals
who eventually develop breast cancer. It is of interest that only
among the relatives of the young probands is age ofbreast cancer
onset significantly lower than for the general population. This
increased breast cancer hazard is not, however, demonstrable
during the premenopausal period but only in the early post-
menopausal period. Relatives of the older (bilateral) probands
have essentially the same distribution of disease onset as the
general population.
Of course, our approach of statistically comparing the entire
families ofbreast cancer patients with the general population does
not give direct evidence for the elevated risk being attributable to
genetic factors only. This method merely allows us to draw the
conclusion that this particular group of women in the family have
an increased incidence ofbreast cancer. Because it offers a quanti-
tative estimate of the risk in families with a history of a malig-
nancy, it provides a new instrument for everyday genetic
counselling (Biesecker et al, 1993; Hoskins et al, 1995), and itmay
also be useful in selecting individuals for screening or prevention
programmes.
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